Cited by 433Smoking Behavior and CessationNicotinic Acetylcholine Receptors StudySubstance Abuse Treatment and Outcomes

The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.

Nicotine receptor partial agonists for smoking cessation

Open access

Cahill, Kate, Lindson-Hawley, Nicola, Thomas, Kyla H, Fanshawe, Thomas R, Lancaster, Tim·2016·Cochrane Database of Systematic Reviews

DOI 10.1002/14651858.cd006103.pub7

Open this paper in CoChat — free account Open PDF

Abstract

Nicotine receptor partial agonists for smoking cessation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/14651858.cd006103.pub7

Cites

230 of 230 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann‐Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,564
Self-citation
Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
Jorenby, D. E. (2006) · JAMA · doi:10.1001/jama.296.1.56 · Cited by 1,635
Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
Gonzales, D. (2006) · JAMA · doi:10.1001/jama.296.1.47 · Cited by 1,361
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Outcome criteria in smoking cessation trials: proposal for a common standard
West, R., Hajek, P., Stead, L., & Stapleton, J. (2005) · Addiction · doi:10.1111/j.1360-0443.2004.00995.x · Cited by 1,285
Pharmacological interventions for smoking cessation: an overview and network meta-analysis
Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009329.pub2 · Cited by 1,243
Self-citation
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.
Anthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Ascher, J., Russ, C., Krishen, A., & Evins, A. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30272-0 · Cited by 1,177
Measures of abstinence in clinical trials: issues and recommendations
Hughes, J. R., Keely, J. P., NIAURA, R. S., Ossip-Klein, D. J., RICHMOND, R. L., & Swan, G. E. (2003) · Nicotine & Tobacco Research · doi:10.1093/ntr/5.1.13 · Cited by 1,058
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930

Flagged first, then by citations

Show all 230 references

Research works printed but not linked: 38

Aubin, 2008, Authors' reply [to JE Rose], Thorax, 63, 752
Aubin, 2008, Authors' reply [to T Hillman], Thorax, 63, 752
Brinn, 2013, Cost effectiveness of an inpatient smoking cessation intervention for patients with tobacco related illnesses (Stop Trial): a multi-centre RCT [Abstract], Respirology (Carlton, Vic.), 18, 16 [O027]
Carson, 2015, Superiority of a course of varenicline tartrate plus counselling over counselling alone for smoking cessation: a 24-month randomized controlled trial for inpatients, Respirology, 20, 115
Carson, 2010, Varenicline tartrate and counselling versus counselling alone in a randomised controlled trial for inpatient smoking cessation: 3 month interim results [Abstract], Respirology, 15, A30
Hnin, 2014, Triggers resulting in relapse: cohort analysis from the smoking termination opportunity for inpatients (STOP) trial [Abstract], Respirology (Carlton, Vic.), 19, 40 [TO 076]
Anthenelli R Benowitz N West R St Aubin L McRae T Lawrence D Reports of suicidal ideation and behavior in the EAGLES trial Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 8
Benowitz N Evins AE West R St Aubin L McRae T Lawrence D EAGLES trial: study design and neuropsychiatric safety results Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 7
Prochaska J Neuropsychiatric risk concerns in the context of smoking, quitting, and cessation pharmacotherapy use Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 7
Prochaska J Benowitz N West R Anthenelli R Evaluating adverse events in a global smoking cessation study (EAGLES): a randomized controlled tiral comparing the safety and efficacy of the first-line smoking cessation aids in smokers with and without pychiatric disorders Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 7
West R Benowitz N Evins AE St Aubin L McRae T Lawrence D Relative efficacy of varenicline, bupropion SR, and nicotine transdermal patch in aiding smoking cessation in the EAGLES trial Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 8
Bastian H Comment on Ebbert 2015 'Reduce to Quit' trial www.ncbi.nlm.nih.gov/pubmed/?term=25688780
Evins, 2013, Extended duration pharmacotherapy with varenicline prevents relapse to smoking in adult smokers with schizophrenia, Neuropsychopharmacology, 38, S63
Meszaros, 2012, Varenicline treatment of alcohol and nicotine dependence in schizophrenia: Problems encountered in a pilot trial, American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions, 21, 393
Nakamura, 2007, Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers, Clinical Therapeutics, 29, 1040, 10.1016/j.clinthera.2007.06.012 · DOI
Rigotti, 2010, A randomized trial of varenicline for smoking cessation in patients with cardiovascular disease: analysis of efficacy by baseline characteristics, Circulation, Conference, 2
Benndorf, 1970, Smoking cessation treatment with cytisin (Tabex®): half-yearly outcomes for former smokers abstinent at four weeks from beginning of treatment, Das Deutsche Gesundheitwesen, 24, 774
Benndorf, 1969, Further reports on a double blind trial of the Bulgarian cytisine compound Tabex® on 1214 smokers wishing to quit and practical experience in conducting clinics for such smokers, Das Deutsche Gesundheitswesen, 24, 1135
Benndorf, 1968, Results of smoking cessation treatment with cytisin (Tabex®), Das Deutsche Gesundheitwesen, 23, 2092
Scharfenberg, 1971, Cytisine (Tabex®) as a treatment for smoking cessation, Das Deutsche Gesundheitwesen, 26, 463
O'Brien, 2007, Varenicline as maintenance therapy, Current Psychiatry Reports, 9, 348
Fagerström, 2010, Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries, Current medical Research & Opinion, 26, 2165, 10.1185/03007995.2010.505130 · DOI
Fagerström, 2010, Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries, Current medical Research & Opinion, 26, 2165, 10.1185/03007995.2010.505130 · DOI
Westergaard, 2014, The effect of varenicline on smoking cessation in a group of young asthma patients, American Journal of Respiratory and Critical Care Medicine, 189, A1091
Reeves K Watsky E Williams K Azoulay S Billing B Gong J The safety of varenicline taken for 52 weeks for smoking cessation [RPOS3-54] Society for Research on Nicotine and Tobacco 12th Annual Conference Orlando Fla, USA 2006
Falk, 2014, A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence, Alcoholism, Clinical and Experimental Research, 38, 139A
Granatowicz, 1976, Smoking cessation through the use of cytisine and other therapy, World Smoking Health, 1, 8
Hartwell, 2014, Pharmacogenetics of naltrexone and varenicline in heavy drinking smokers, Alcoholism, Clinical and Experimental Research, 38, 223A
Bacvarov, 1967, Smoking cessation through medication: remarks on G. Scharfenberg, E Winkelvoss and S. Benndorf, Munch Med Wschr. 109 (1967) 1687-1689, Munchener Medizinische Wochenschrift, 109, 2663
Kempe, 1967, Observation about the Bulgarian medicine for smoking withdrawal Tabex, produced by Pharmachim-Sofia, Savr Med, 18, 355
Paun, 1968, [Smoking cessation with cytisine 'Tabex' tablets] [German], Sonderduck aus das deutsche Gesundheitwesen, 23, 2088
Paun, 1970, Tabex: registering and treatment of smokers with chronic bronchitis in the consultation against tobacco smoking - Berlin, Medico-Biologic Information, 3, 15
Shim, 2011, Varenicline treatment for smoking cessation in people with schizophrenia: a randomized double-blind placebo-controlled trial, Schizophrenia Bulletin, 37, 320
Stoyanov, 1972, [On the therapeutic effectiveness and tolerability of Tabex] [Bulgarian], Savremenna Medicina, 23, 30
Wiratmoko, 2013, Efficacy of varenicline, an nicotinic acetylcholine receptor partial agonist, vs placebo for smoking cessation. A randomized controlled trial, Respirology (Carlton, Vic.), 18, 66 [OS205]
Reid, 2010, Varenicline versus transdermal nicotine patch for smoking cessation in patients with coronary heart disease: A pilot randomized trial, Canadian Journal of Cardiology, 26, 53D
Smith, 2013, Varenicline effects on smoking, cognition, and psychiatric symptoms in schizophrenia, Neuropsychopharmacology, 38, S364
Tutka, 2006, Cytisine - renaissance of well known alkaloid. Pharmacological aspects of efficacy in the treatment of tobacco dependence [Polish], Farmakoterapia w Psychiatrii i Neurologii, 1, 33

Sorted by citations

Items 101–200 of 432

Unlocking Nicotinic Selectivity via Direct C‒H Functionalization of (−)-Cytisine
Campello, H. R., del Villar, S. G., Honraedt, A., Minguez, T., Oliveira, A. S. F., Ranaghan, K. E., Shoemark, D. K., Bermúdez, I., Gotti, C., Sessions, R. B., et al. (2018) · Chem · doi:10.1016/j.chempr.2018.05.007 · Cited by 39
The current state of tobacco cessation treatment
Choi, H., Ataucuri-Vargas, J., Lin, C., & Singrey, A. M. (2021) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.20099 · Cited by 43
Smoking Cessation for Smokers Not Ready to Quit: Meta-analysis and Cost-effectiveness Analysis
Ali, A., Kaplan, C. M., Derefinko, K. J., & Klesges, R. C. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.04.021 · Cited by 38
Effectiveness of smoking cessation interventions among adults: an overview of systematic reviews
Hersi, M., Beck, A., Hamel, C., Esmaeilisaraji, L., Pussegoda, K., Austin, B., Ahmadzai, N., Pratt, M., Thuku, M., Yazdi, F., et al. (2024) · Systematic Reviews · doi:10.1186/s13643-024-02570-9 · Cited by 46
Short-term benefit of smoking cessation along with glycopirronium on lung function and respiratory symptoms in mild COPD patients: a retrospective study
Pezzuto, A., Stellato, M., Catania, G., Mazzara, C., Tonini, S., Caricato, M., Crucitti, P., & Tonini, G. (2018) · Journal of Breath Research · doi:10.1088/1752-7163/aad0a8 · Cited by 37
The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data
Rollema, H., & Hurst, R. S. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4921-9 · Cited by 42
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial of Cytisinicline in Adult Smokers (The ORCA-1 Trial)
Nides, M. A., Rigotti, N. A., Benowitz, N. L., Clarke, A., & Jacobs, C. A. (2021) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntab073 · Cited by 38
Regulation of cocaine-related behaviours by estrogen and progesterone
Peart, D. R., Andrade, A. K., Logan, C. N., Knackstedt, L. A., & Murray, J. E. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104584 · Cited by 36
Probing Binding Interactions of Cytisine Derivatives to the α4β2 Nicotinic Acetylcholine Receptor.
Blom, A. M., Campello, H., Lester, H., Gallagher, T., & Dougherty, D. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b06580 · Cited by 22
Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses
Lindson, N., Theodoulou, A., Livingstone‐Banks, J., Aveyard, P. N., Fanshawe, T. R., Ordóñez-Mena, J. M., Sutton, A. J., Freeman, S. C., Agrawal, S., & Hartmann‐Boyce, J. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015226 · Cited by 33
Self-citation
Food Addiction and Tobacco Use Disorder: Common Liability and Shared Mechanisms
Zawertailo, L. A., Attwells, S., deRuiter, W. K., Le, T. L., Dawson, D., & Selby, P. L. (2020) · Nutrients · doi:10.3390/nu12123834 · Cited by 37
Tobacco Harms, Nicotine Pharmacology, and Pharmacologic Tobacco Cessation Interventions for Women
Baraona, L. K., Lovelace, D. L., Daniels, J. L., & McDaniel, L. R. (2017) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12616 · Cited by 34
Varenicline and related interventions on smoking cessation: A systematic review and network meta-analysis
Guo, K., Zhou, L., Shang, X., Yang, C., Fenfen, E., Wang, Y., Xu, M., Wu, Y., Li, Y., Li, M., et al. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109672 · Cited by 34
Clinical Practice Guideline of Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on Pharmacological Treatment of Tobacco Dependence 2023
Rábade, C., de Granda‐Orive, J. I., Riesco-Miranda, J. A., de Higes-Martínez, E., Pinedo, Á. R., Cabrera-César, E., Miñana, J. S.-C., García-Rueda, M., Esplá, E. P., & Jimenez-Ruiz, C. A. (2023) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2023.07.024 · Cited by 37
Heated tobacco products for smoking cessation and reducing smoking prevalence
Tattan‐Birch, H., Jackson, S. E., Shahab, L., Hartmann‐Boyce, J., Kock, L. S., Simonavičius, E., Brose, L. S., & Brown, J. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013790 · Cited by 29
A SMARTTT approach to Treating Tobacco use disorder in persons with HIV (SMARTTT): Rationale and design for a hybrid type 1 effectiveness-implementation study
Edelman, E. J., Dziura, J. D., Deng, Y., Bold, K. W., Murphy, S. M., Porter, E., Sigel, K. M., Yager, J. E., Ledgerwood, D. M., & Bernstein, S. L. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106379 · Cited by 29
The effectiveness of using e‐cigarettes for quitting smoking compared to other cessation methods among adults in the United Kingdom
McDermott, M. S., East, K. A., Brose, L. S., McNeill, A. D., Hitchman, S. C., & Partos, T. (2021) · Addiction · doi:10.1111/add.15474 · Cited by 29
The effect of Varenicline and Bupropion on smoking cessation: A network meta-analysis of 20 randomized controlled trials
Guo, K., Wang, S., Shang, X., Fenfen, E., Hou, L., Li, J., Li, Y., Yang, K., & Li, X. (2022) · Addictive Behaviors · doi:10.1016/j.addbeh.2022.107329 · Cited by 32
Non‐invasive brain stimulation for smoking cessation: a systematic review and meta‐analysis
Petit, B., Dornier, A., Meille, V., Demina, A., & Trojak, B. (2022) · Addiction · doi:10.1111/add.15889 · Cited by 33
Estimates of effectiveness and reach for ‘return on investment’ modelling of smoking cessation interventions using data from England
West, R., Coyle, K., Owen, L., Coyle, D., Pokhrel, S., & On behalf of the EQUIPT Study Group (2017) · Addiction · doi:10.1111/add.14006 · Cited by 29
Reprint of: Prevention and Treatment of Tobacco Use
Kalkhoran, S. M., Benowitz, N. L., & Rigotti, N. A. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.020 · Cited by 27
Consensus statement on smoking cessation in patients with pain
Iida, H., Yamaguchi, S., Goyagi, T., Sugiyama, Y., Taniguchi, C., Matsubara, T., Yamada, N., Yonekura, H., & Iida, M. (2022) · Journal of Anesthesia · doi:10.1007/s00540-022-03097-w · Cited by 28
Real-time video counselling for smoking cessation
Tzelepis, F., Paul, C. L., Williams, C. M., Gilligan, C., Regan, T. W., Daly, J., Hodder, R. K., & Wiggers, J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012659 · Cited by 27
Systematic review and meta‐analyses of cytisine to support tobacco cessation
Puljević, C., Stjepanović, D., Meciar, I., Kang, H., Chan, G., Morphett, K., Bendotti, H., Kunwar, G., & GARTNER, C. E. (2024) · Addiction · doi:10.1111/add.16592 · Cited by 26
2013 ESH/ESC GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION
Mancia, G., Fagard, R. H., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T. C., Cífková, R., Backer, G. D., Dominiczak, A. F., et al. (2014) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2014-1-7-94 · Cited by 26
Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes
Russo, C., Walicka, M., Caponnetto, P., Cibella, F., Maglia, M. G., Alamo, A., Campagna, D., Frittitta, L., Mauro, M. D., Caci, G., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.17709 · Cited by 26
The safety, effectiveness and cost‐effectiveness of cytisine in achieving six‐month continuous smoking abstinence in tuberculosis patients—protocol for a double‐blind, placebo‐controlled randomized trial
Dogar, O. F., Barua, D., Boeckmann, M., Elsey, H., Fatima, R., Gabe, R., Huque, R., Keding, A., Khan, A., Kotz, D., et al. (2018) · Addiction · doi:10.1111/add.14242 · Cited by 26
Comparison of monoamine oxidase inhibition by cigarettes and modified risk tobacco products
van der Toorn, M., Koshibu, K., Schlage, W. K., Majeed, S., Pospíšil, P., Hoeng, J., & Peitsch, M. C. (2019) · Toxicology Reports · doi:10.1016/j.toxrep.2019.11.008 · Cited by 25
Automated Digital Interventions and Smoking Cessation: Systematic Review and Meta-analysis Relating Efficiency to a Psychological Theory of Intervention Perspective
Sha, L., Yang, X., Deng, R., Wang, W., Tao, Y., Cao, H.-L., Ma, Q., Wang, H., Nie, Y., Leng, S., et al. (2022) · Journal of Medical Internet Research · doi:10.2196/38206 · Cited by 25
Evaluation of the effectiveness of cytisine for the treatment of smoking cessation: A systematic review and meta‐analysis
Santi, O. D., Orellana, M., Niro, C. A. D., & Greco, V. (2023) · Addiction · doi:10.1111/add.16399 · Cited by 27
Sex differences in the association of cigarette craving with insula structure
Perez Diaz, M., Pochon, J.-B., Ghahremani, D. G., Dean, A. C., Faulkner, P., Petersen, N., Tyndale, R. F., Donis, A., Paez, D., Cahuantzi, C., et al. (2021) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab015 · Cited by 24
Update on the approach to smoking in patients with respiratory diseases
Sales, M. P. U., de Araújo, A. J., Chatkin, J. M., Godoy, I., Pereira, L. F. F., Castellano, M. V. C. D. O., Tanni, S. É., de Almeida, A. Á., Chatkin, G., da Silva, L. C. C., et al. (2019) · Jornal Brasileiro de Pneumologia · doi:10.1590/1806-3713/e20180314 · Cited by 30
Tobacco Use and Treatment of Tobacco Dependence Among People With Human Immunodeficiency Virus: A Practical Guide for Clinicians
Reddy, K. P., Kruse, G. R., Lee, S., Shuter, J., & Rigotti, N. A. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab1069 · Cited by 24
Cost‐effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD
Trapero‐Bertran, M., Muñoz, C., Coyle, K., Coyle, D., Lester‐George, A., Leidl, R., Németh, B., Cheung, K. L., Pokhrel, S., & Nicolás, Á. L. (2018) · Addiction · doi:10.1111/add.14090 · Cited by 23
Anti-cholinergics mecamylamine and scopolamine alleviate motion sickness-induced gastrointestinal symptoms through both peripheral and central actions
Qi, R., Su, Y., Pan, L., Mao, Y., Liang, L., Dai, Z., Wang, J., & Cai, Y. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.12.006 · Cited by 23
Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial
Anthenelli, R. M., Gaffney, M., Benowitz, N. L., West, R., McRae, T. D., Russ, C., Lawrence, D., Aubin, L. S., Krishen, A., & Evins, A. E. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-04858-2 · Cited by 23
Factors Associated with Successful Smoking Cessation According to Age Group: Findings of an 11-Year Korea National Survey
Kim, Y., Lee, J. S., & Cho, W. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041576 · Cited by 24
Tobacco smoking, related harm and motivation to quit smoking in people with schizophrenia spectrum disorders
Caponnetto, P., Polosa, R., Robson, D., & Bauld, L. (2020) · Health Psychology Research · doi:10.4081/hpr.2020.9042 · Cited by 24
Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients
Gossec, L., Soubrier, M., Foissac, F., Moltó, A., Richette, P., Beauvais, C., Ruyssen‐Witrand, A., Perdriger, A., Chary-Valckenaere, I., Mouterde, G., et al. (2019) · RMD Open · doi:10.1136/rmdopen-2019-000914 · Cited by 22
Maintaining abstinence from smoking after a period of enforced abstinence – systematic review, meta-analysis and analysis of behaviour change techniques with a focus on mental health
Brose, L. S., Simonavičius, E., & McNeill, A. D. (2017) · Psychological Medicine · doi:10.1017/s0033291717002021 · Cited by 22
Declaración Oficial de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR) sobre cigarrillos electrónicos e IQOS®
Signes‐Costa, J., de Granda‐Orive, J. I., Pinedo, Á. R., Escrig, A. C., Martínez, E. D. H., Rábade, C., César, E. C., & Jimenez-Ruiz, C. A. (2019) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2019.04.023 · Cited by 22
Nicotine dependence (trait) and acute nicotinic stimulation (state) modulate attention but not inhibitory control: converging fMRI evidence from Go–Nogo and Flanker tasks
Lesage, E., Sutherland, M. T., Ross, T. J., Salmeron, B. J., & Stein, E. A. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0623-1 · Cited by 25
The Relationship of Varenicline Agonism of α4β2 Nicotinic Acetylcholine Receptors and Nicotine-Induced Dopamine Release in Nicotine-Dependent Humans
McCaul, M. E., Wand, G. S., Kuwabara, H., Dannals, R. F., Wong, D. F., & Xu, X. (2019) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntz080 · Cited by 24
Does the nicotine metabolite ratio moderate smoking cessation treatment outcomes in real‐world settings? A prospective study
Shahab, L., Bauld, L., McNeill, A. D., & Tyndale, R. F. (2018) · Addiction · doi:10.1111/add.14450 · Cited by 21
Thoracic Surgeons’ Beliefs and Practices on Smoking Cessation Before Lung Resection
Marrufo, A. S., Kozower, B. D., Tancredi, D. J., Nuno, M. A., Cooke, D. T., Pollock, B. H., Romano, P. S., & Brown, L. M. (2018) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2018.11.055 · Cited by 21
Electronic Cigarette Cessation in Youth and Young Adults: A Case Series
Sikka, G., Oluyinka, M., Schreiber, R., & Galiatsatos, P. (2021) · Tobacco Use Insights · doi:10.1177/1179173x211026676 · Cited by 21
Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)—a structured summary of a study protocol for a randomized controlled study
Lengsfeld, S., Burkard, T., Meienberg, A., Jeanloz, N., Coynel, D., Vogt, D. R., Hemkens, L. G., Speich, B., Zanchi, D., Erlanger, T. E., et al. (2023) · Trials · doi:10.1186/s13063-023-07164-9 · Cited by 20
Predictors of long-term smoking cessation among smokers enrolled in a university smoking cessation program
Joo, H., Cho, M. H., Cho, Y., Joh, H., & Kim, J. W. (2020) · Medicine · doi:10.1097/md.0000000000018994 · Cited by 21
Cytisine: State of the art in pharmacological activities and pharmacokinetics
Wang, X., Yang, J., Huang, P., Wang, D., Zhang, Z., Zhou, Z., Liang, L., Yao, R., & Long, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116210 · Cited by 22
The effectiveness, safety and cost‐effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non‐inferiority trial
Thomas, D., Farrell, M., McRobbie, H. J., Tutka, P., Petrie, D., West, R., Siahpush, M., GARTNER, C. E., Walker, N. K., Mendelsohn, C. P., et al. (2018) · Addiction · doi:10.1111/add.14541 · Cited by 19
Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): A randomized controlled clinical trial
Carson‐Chahhoud, K., Smith, B. J., Peters, M. J., Brinn, M. P., Ameer, F., Singh, K., Fitridge, R., Koblar, S. A., Jannes, J., Veale, A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231095 · Cited by 19
Randomised, placebo-controlled, double-blind, double-dummy, multicentre trial comparing electronic cigarettes with nicotine to varenicline and to electronic cigarettes without nicotine: the ECSMOKE trial protocol
Berlin, I., Dautzenberg, B., Lehmann, B., Palmyre, J., Liégey, E., Rycke, Y. D., & Tubach, F. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028832 · Cited by 20
2023 AHA/ACC Clinical Performance and Quality Measures for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures
DEHMER, G. J., Grines, C. L., Bakaeen, F. G., Beasley, D. L., Beckie, T. M., Boyd, J. H., Cigarroa, J. E., Das, S. R., Diekemper, R. L., Frampton, J., et al. (2023) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000121 · Cited by 18
Increased thalamic volume and decreased thalamo-precuneus functional connectivity are associated with smoking relapse
Wang, C., Wang, S., Shen, Z., Qian, W. P., Jiaerken, Y., Luo, X., Li, K., Zeng, Q., Gu, Q., Yang, Y., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102451 · Cited by 18
Pilot Randomized Trial of an Automated Smoking Cessation Intervention via Mobile Phone Text Messages as an Adjunct to Varenicline in Primary Care
Yingst, J. M., Veldheer, S., Hrabovsky, S., Hammett, E., Nicholson, J. M., Berg, A. S., & Foulds, J. (2018) · Journal of Health Communication · doi:10.1080/10810730.2018.1453890 · Cited by 18
How to manage cigarette smoking in kidney transplant candidates and recipients?
Devresse, A., Gohy, S. T., Robert, A., & Kanaan, N. (2021) · Clinical Kidney Journal · doi:10.1093/ckj/sfab072 · Cited by 16
The use of biomarkers to guide precision treatment for tobacco use
Siegel, S. D., Tindle, H. A., Bergen, A. W., Tyndale, R. F., & Schnoll, R. A. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100076 · Cited by 17
Varenicline treatment for methamphetamine dependence: A randomized, double-blind phase II clinical trial
Briones, M. S., SHOPTAW, S. J., Cook, R., Worley, M. J., Swanson, A., Moody, D. E., Fang, W. B., TSUANG, J. W., Furst, B. A., & Heinzerling, K. G. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.04.023 · Cited by 18
Minding the brain: the role of pharmacotherapy in substance-use disorder treatment
Dakwar, E., & Kleber, H. D. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.3/hkleber · Cited by 17
A pilot randomized trial examining the feasibility and acceptability of a culturally tailored and adherence-enhancing intervention for Latino smokers in the U.S.
de Dios, M. A., Cano, M. Á., Vaughan, E. L., Childress, S. D., McNeel, M. M., Harvey, L. M., & NIAURA, R. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210323 · Cited by 17
Well-being and harm reduction, the consolidated reality of electronic ciga rettes ten years later from this emerging phenomenon: A narrative review
Caponnetto, P. (2020) · Health Psychology Research · doi:10.4081/hpr.2020.9463 · Cited by 16
Official statement of the Spanish society of pulmonology and thoracic surgery (SEPAR) on electronic cigarettes and IQOS®
Signes‐Costa, J., de Granda‐Orive, J. I., Pinedo, Á. R., Escrig, A. C., Martínez, E. D. H., Rábade, C., César, E. C., & Jimenez-Ruiz, C. A. (2019) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2019.04.007 · Cited by 17
Differential patterns of alcohol and nicotine intake: Combined alcohol and nicotine binge consumption behaviors in mice
DeBaker, M. C., Robinson, J. M., Moen, J. K., Wickman, K. D., & Lee, A. M. (2019) · Alcohol · doi:10.1016/j.alcohol.2019.09.006 · Cited by 16
The dual orexin receptor antagonist TCS1102 does not affect reinstatement of nicotine-seeking
Khoo, S. Y., McNally, G. P., & Clemens, K. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173967 · Cited by 16
A systematic review and meta-analysis of interventions to induce attempts to quit tobacco among adults not ready to quit.
Klemperer, E. M., Streck, J. M., Lindson, N., West, J. C., Su, A., Hughes, J. R., & Carpenter, M. J. (2022) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000583 · Cited by 16
The effectiveness of smoking cessation interventions in rural and remote populations: Systematic review and meta-analyses
Vance, L., Glanville, B., Ramkumar, K., Chambers, J., & Tzelepis, F. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2022.103775 · Cited by 16
Cardiovascular and neuropsychiatric safety of smoking cessation pharmacotherapies in non‐depressed adults: a retrospective cohort study
Carney, G., Bassett, K. L., Maclure, M., Taylor, S., & Dormuth, C. R. (2020) · Addiction · doi:10.1111/add.14951 · Cited by 15
Exploring the barriers and facilitators to the uptake of smoking cessation services for people in treatment or recovery from problematic drug or alcohol use: A qualitative systematic review
Iyahen, E. O., Omoruyi, O. O., Rowa‐Dewar, N., & Dobbie, F. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288409 · Cited by 13
Les outils du sevrage tabagique en 2018
Abdul-Kader, J., Airagnes, G., d’Almeida, S., Limosin, F., & Faou, A.-L. L. (2018) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2018.03.004 · Cited by 18
Multimodal Smoking Cessation in a Real-Life Setting: Combining Motivational Interviewing With Official Therapy and Reduced Risk Products
Caponnetto, P., DiPiazza, J., Cappello, G. C., Demma, S., Maglia, M. G., & Polosa, R. (2019) · Tobacco Use Insights · doi:10.1177/1179173x19878435 · Cited by 14
Frequently Reported Adverse Events With Smoking Cessation Medications: Post Hoc Analysis of a Randomized Trial
Ebbert, J. O., Jimenez-Ruiz, C. A., Dutro, M. P., Fisher, M., Li, J., & Hays, J. T. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.10.046 · Cited by 14
Optimal use of smoking cessation pharmacotherapy
Mendelsohn, C. P. (2022) · Australian Prescriber · doi:10.18773/austprescr.2022.001 · Cited by 17
Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non‐inferiority trial
Walker, N. K., Smith, B. D., Barnes, J., Verbiest, M. E. A., Kurdziel, T., Parag, V., Pokhrel, S., & Bullen, C. (2018) · Addiction · doi:10.1111/add.14449 · Cited by 14
Using the Social-Local-Mobile App for Smoking Cessation in the SmokeFreeBrain Project: Protocol for a Randomized Controlled Trial
Sánchez, F. J., Hernández, L. C., Núñez-Benjumea, F. J., González, M. M., Moreno-Conde, J., Parra-Calderón, C. L., Fernández-Luque, L., Hors-Fraile, S., Civit, A., Bamidis, P. D., et al. (2018) · JMIR Research Protocols · doi:10.2196/12464 · Cited by 14
Functional benefit of smoking cessation in severe COPD patients undergoing bronchial valve implantation
Pezzuto, A., D’Ascanio, M., Grieco, A., & Rícci, A. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.07.032 · Cited by 14
Longitudinal Associations Between Smoking Cessation Medications and Alcohol Consumption Among Smokers in the International Tobacco Control Four Country Survey
McKee, S. A., Young‐Wolff, K. C., Harrison, E. L. R., Cummings, K. M., Borland, R., Kahler, C. W., Fong, G. T., & Hyland, A. J. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12041 · Cited by 14
Repetitive transcranial magnetic stimulation for smoking cessation: Next steps for translation and implementation into clinical practice
Tang, V. M., Goud, R., Zawertailo, L. A., Selby, P. L., Coroiu, A., Sloan, M. E., Chenoweth, M. J., Buchman, D. Z., Ibrahim, C., Blumberger, D. M., et al. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115340 · Cited by 15
Lung cancer screening in Brazil: recommendations from the Brazilian Society of Thoracic Surgery, Brazilian Thoracic Association, and Brazilian College of Radiology and Diagnostic Imaging
Pereira, L. F. F., dos Santos, R. S., Bonomi, D. O., Franceschini, J., Santoro, I. L., Miotto, A., de Sousa, T. L. F., Chate, R. C., Hochhegger, B., Neto, A. G., et al. (2024) · Jornal Brasileiro de Pneumologia · doi:10.36416/1806-3756/e20230233 · Cited by 53
The potential of new nicotine and tobacco products as tools for people who smoke to quit combustible cigarettes – a systematic review of common practices and guidance towards a robust study protocol to measure cessation efficacy
Pluym, N., Burkhardt, T., Scherer, G., & Scherer, M. (2024) · Harm Reduction Journal · doi:10.1186/s12954-024-01047-1 · Cited by 14
Varenicline for smoking cessation: Is it a heartbreaker?
Hays, J. T. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.110804 · Cited by 13
Smoking, alcohol, and nutritional status in relation to one-year mortality in Danish stage I lung cancer patients
Christensen, N. L., Løkke, A., Dalton, S. O., Christensen, J., & Rasmussen, T. R. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.07.025 · Cited by 13
Subsidized pharmacological treatment for smoking cessation by the Spanish public health system: A randomized, pragmatic, clinical trial by clusters
Minué-Lorenzo, C., Olano-Espinosa, E., del Cura-González, I., Vizcaíno-Sánchez, J., Guillem, F. C., Granados-Garrido, J., Ruiz-Pacheco, M., Gámez-Cabero, M. I., Martinez-Suberviola, F. J., & Serrano, M. E. S. (2019) · Tobacco Induced Diseases · doi:10.18332/tid/111368 · Cited by 13
2023 AHA/ACC Clinical Performance and Quality Measures for Coronary Artery Revascularization
DEHMER, G. J., Grines, C. L., Bakaeen, F. G., Beasley, D. L., Beckie, T. M., Boyd, J. H., Cigarroa, J. E., Das, S. R., Diekemper, R. L., Frampton, J., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.03.409 · Cited by 13
Clinical challenges facing patient participation in cardiac rehabilitation: cigarette smoking
Gaalema, D. E., Khadanga, S., & Pack, Q. R. (2023) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2023.2282026 · Cited by 14
Interventions for smokeless tobacco use cessation
Livingstone‐Banks, J., Vidyasagaran, A. L., Croucher, R., Siddiqui, F., Zhu, S., Kidwai, Z., Parkhouse, T., Mehrotra, R., & Siddiqi, K. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015314.pub2 · Cited by 13
Preclinical evidence for combining the 5‐ HT2C receptor agonist lorcaserin and varenicline as a treatment for nicotine dependence
Fletcher, P. J., Li, Z., Silenieks, L. B., MacMillan, C., DeLannoy, I., & Higgins, G. A. (2018) · Addiction Biology · doi:10.1111/adb.12602 · Cited by 12
Tobacco carcinogens and the methionine metabolism in human bladder cancer
Wojtczyk-Miaskowska, A., & Schlichtholz, B. (2019) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2019.06.001 · Cited by 12
Outcomes and predictive factors for successful smoking cessation therapy in COPD patients with nicotine dependence
Hashimoto, R., Tomioka, H., Wada, T., & Yoshizumi, Y. (2020) · Respiratory Investigation · doi:10.1016/j.resinv.2020.03.007 · Cited by 12
Highly Selective and Potent α4β2 nAChR Antagonist Inhibits Nicotine Self-Administration and Reinstatement in Rats
Wu, J., Cippitelli, A., Zhang, Y., Debevec, G., Schoch, J., Ozawa, A., Yu, Y., Liu, H., Chen, W., Houghten, R. A., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01250 · Cited by 13
Cytisine for smoking cessation: A 40-day treatment with an induction period
Tinghino, B., Cardellicchio, S., Corso, F., Cresci, C., Pittelli, V., Principe, R., Siracusano, L., Zelano, G., Zagà, V., & Cattaruzza, M. S. (2024) · Tobacco Prevention & Cessation · doi:10.18332/tpc/187556 · Cited by 13
Risk of neuropsychiatric and cardiovascular adverse events following treatment with varenicline and nicotine replacement therapy in the UK Clinical Practice Research Datalink: a case–cross‐over study
Thomas, K. H., Davies, N. M., Taylor, A. E., Taylor, G. M. J., Gunnell, D., Martin, R. M., & Douglas, I. (2020) · Addiction · doi:10.1111/add.15338 · Cited by 10
Self-citation
Preguntas y respuestas en tabaquismo
Mavárez, J. D. Á., Villalona, R. M., Moreno, B. R., Calvo, G. S., César, E. C., & de Higes-Martínez, E. B. (2023) · Open Respiratory Archives · doi:10.1016/j.opresp.2022.100230 · Cited by 13
Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment
Bozinoff, N., & Foll, B. L. (2018) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2018.1507736 · Cited by 11
Evaluations of clinical tobacco cessation interventions in Arab populations: A systematic review
Alzahrane, A., West, R., Ubhi, H. K., Brown, J., Abdulqader, N., & Samarkandi, O. A. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.08.017 · Cited by 11
Design of a randomized controlled trial of smoking cessation medications for alcohol reduction among HIV-positive heavy drinkers and daily smokers in St. Petersburg, Russia
Tindle, H. A., Freiberg, M. S., Gnatienko, N., Blokhina, E. A., Cheng, D. M., Yaroslavtseva, T. V., Bendiks, S., Winter, M. R., Krupitsky, E. M., & Samet, J. H. (2020) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2020.100625 · Cited by 11
Translational Research in Nicotine DependencePreprint
Turner, J. R., Gold, A. B., Schnoll, R. A., & Blendy, J. A. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012153 · Cited by 11
The impact of three weeks of pre-quit varenicline on reinforcing value and craving for cigarettes in a laboratory choice procedure
Lawson, S. C., Gass, J. C., Cooper, R. K., Tonkin, S., Colder, C. R., Mahoney, M. C., Tiffany, S. T., & Hawk, L. W. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05713-7 · Cited by 10
5-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence
Higgins, G. A., & Sellers, E. M. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.007 · Cited by 10
Cost-Effectiveness Analysis of Tobacco Control Strategies in Indonesia
Matheos, C. C., Liew, D., Zomer, E., & Ademi, Z. (2022) · Value in Health Regional Issues · doi:10.1016/j.vhri.2022.08.013 · Cited by 10
Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement
Cinciripini, P. M., Green, C. E., Shete, S. S., Minnix, J. A., Robinson, J. D., Cui, Y., Kim, S., Kypriotakis, G., Beneventi, D., Blalock, J. A., et al. (2024) · JAMA · doi:10.1001/jama.2024.4183 · Cited by 10

Authors: Cahill, K., Lindson-Hawley, N., Thomas, K. H., Fanshawe, T. R., & Lancaster, T.
Affiliations: University of Oxford (GB)
University of Oxford; Nuffield Department of Primary Care Health Sciences; Radcliffe Observatory Quarter Woodstock Road Oxford UK OX2 6GG
University of Bristol (GB)
ORCID: Thomas, Kyla H
Fanshawe, Thomas R
Venue: Cochrane Database of Systematic Reviews
Publisher: Wiley
Published: 2016-05-09
ISSN: 1361-6137 (ISSN-L)
1465-1858
DOI: 10.1002/14651858.cd006103.pub7
OpenAlex: W4294253676
Cited by: 433
References: 230
Citations by year: 2026: 5 · 2025: 22 · 2024: 32 · 2023: 57 · 2022: 55 · 2021: 65 · 2020: 34 · 2019: 52 · 2018: 49 · 2017: 43 · 2016: 8
FWCI: 6.00
Type: journal article
Language: en
Update notices: new_version (2023-05-05)
Open access: bronze
doi.org
Locations: Cochrane Database of Systematic Reviews (publishedVersion)
Bristol Research (University of Bristol) (publishedVersion, other-oa)
Research Portal (King's College London) (submittedVersion)
Explore Bristol Research (submittedVersion, other-oa)
Funders: National Institute for Health and Care Research (15/58/18, HTA/15/58/18, CL-2013-25-003)
Academy of Medical Sciences (AMS-SGCL12-Thomas)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords: nicotine receptor partial agonist, smoking cessation, nicotine replacement therapy, varenicline, bupropion, nicotine dependence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nicotine receptor partial agonists for smoking cessation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks